Category: by country

Duke University lung researchers cough up fourth retraction, due to “inconsistent” data

Journal of Applied PhysiologyThe Journal of Applied Physiology has retracted a 2012 respiratory study after the authors found “inconsistent” data that “could not be traced to their source.” It’s the fourth retraction for two of the researchers, including Erin Potts-Kant, who was arrested in 2013 for embezzling more than $14,000 from Duke University.

The study, “Effects of corticosteroid treatment on airway inflammation, mechanics, and hyperpolarized 3He magnetic resonance imaging in an allergic mouse model,” looked at how corticosteroid therapy, a steroid treatment used for asthma, worked on mice. It’s been cited four times, according to Thomson Scientific’s Web of Knowledge, and was one of the products of the environmental lung health research conducted by Potts-Kant and Duke professor William Foster, the other co-author on the retracted studies.

Here’s the complete retraction notice: Continue reading Duke University lung researchers cough up fourth retraction, due to “inconsistent” data

Macchiarini co-author objects to investigation’s misconduct verdict

dr-paolo-macchiarini
Paolo Macchiarini

One of Paolo Macchiarini’s co-authors on a 2011 Lancet paper describing an allegedly groundbreaking procedure to transplant an artificial trachea seeded with stem cells is objecting to a recent investigation that concluded Macchiarini had committed misconduct.

Ola Hermanson, who studies neural stem cells at Karolinska Institutet, argued in a report dated June 29 that the investigation contained “serious flaws and formal errors.”

Hermanson’s lengthy response (uploaded here except for supporting emails) is to the findings of an external review of allegations about Macchiarini’s work, conducted by Bengt Gerdin, of Uppsala University. In regards to the 2011 Lancet paper, Gerdin’s investigation found:

Continue reading Macchiarini co-author objects to investigation’s misconduct verdict

“Values were outside expected ranges”: Toxicology paper spiked after audit

Toxicological PathologyResearchers at the National Institute of Environmental Health Sciences have retracted a 2014 article after a review unearthed unresolved problems with the study’s control material.

The retracted paper, “Effect of Temperature and Storage Time on Sorbitol Dehydrogenase Activity in Sprague-Dawley Rat Serum and Plasma,” looked to test the durability and stability of sorbitol dehydrogenase, an enzyme used to detect cancerous liver damage in rats.

Here’s the complete retraction notice from Toxicologic Pathology :

Continue reading “Values were outside expected ranges”: Toxicology paper spiked after audit

JBC cancer paper felled by duplication is one author’s second retraction this month

25.coverA 2002 paper in the Journal of Biological Chemistry on how lung cancer cells resist death has been retracted for duplicating figures from a 2001 paper.

The retracted paper, “Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis,” shares the first and last authors with the 2001 paper, in Oncogene, as well as two other co-authors.

Here’s JBC’s entire retraction note, a sub-genre with which we’ve become intimately familiar by now:

Continue reading JBC cancer paper felled by duplication is one author’s second retraction this month

Accounting professor notches 30 (!) retractions after misconduct finding

James Hunton, via Bentley University
James Hunton, via Bentley University

It began with a retraction due to a “misstatement” in November 2012, which led to an investigation that found the first author, James E. Hunton, guilty of misconduct.  Now, the floodgates have opened, and Hunton has 31 retractions under his belt, making him the newest addition to the Retraction Watch leaderboard.

A month after the first retraction in 2012, Hunton resigned from his accounting professorship at Bentley University, citing family and health concerns.

Then, in 2014, a university investigation concluded that Hunton fabricated data in two papers and may have destroyed evidence. The first paper was the one retracted from Accounting Review for a misstatement; the second was retracted from Contemporary Accounting Research in December 2014. Even though the investigation centered around two publications, the university suggested more may be affected:

Continue reading Accounting professor notches 30 (!) retractions after misconduct finding

Two more retractions make four for bone researcher

JAnatBone anatomists have retracted two papers on primate jawbone structure from the Journal of Anatomy due to “errors in the validation protocol and data,” marking the fourth retraction for one of the authors.

Olga Panagiotopoulou retracted two other papers over the past year, all of which were due to a common methodological problem. As Panagiotopoulou — who completed the work in the UK, before joining the University of Queensland in Australia in 2013 —  explained to us in April,

Continue reading Two more retractions make four for bone researcher

A tale of two journals: Elsevier retracts paper after publishing it in the wrong journal

EMIf you happen to pick up this month’s issue of Economic Modelling, there’s a little surprise on page 307—blank pages. Publisher Elsevier has retracted a paper from that space because it “inadvertently published” the paper in the journal. In fact, Elsevier meant to include the paper in the pages of its other journal, Energy Economics.

The paper, “An Approach to Computing Marginal Land-Use Change Carbon Intensities for Bioenergy in Policy Applications,” is most assuredly not about economic modeling. Rather, it describes an approach for assessing carbon emissions from the production of bioenergy crops.

Here’s the retraction notice: Continue reading A tale of two journals: Elsevier retracts paper after publishing it in the wrong journal

Lost your data? Blame an earthquake

coverJNC

A natural disaster is to blame for a retraction about lethal brain tumors. At least, that’s where the authors say the problem started: with a 2010 earthquake that caused a loss of “substantial data.”

The paper, “Superoxide-dependent uptake of vitamin C in human glioma cells,” looks at how the cells of lethal brain tumors interact with the vitamin commonly used to reduce side effects of therapies.

Post earthquake, someone digitally filled in a western blot analysis of proteins from a cell line and rat brains, as a “temporary solution.” And then the temporary solution made its way into the Journal of Neurochemistry.

Here’s the retraction note from the journal, including an image of the sneaky western blot:

Continue reading Lost your data? Blame an earthquake

Oncogene to retract breast cancer paper following years-old misconduct investigation

Oncogene is retracting a 2010 paper on the molecular details of breast cancer cells as they undergo metastasis following an investigation that discovered the first author had committed misconduct.

The thing is, the investigation concluded in 2012, and the paper — “miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers” — isn’t being retracted until next week.

According to Lucinda Haines, senior publishing manager at Nature Publishing Group, the paper will be retracted June 29.

We heard from Iris Behrmann, Head of the Life Sciences Research Unit at the University of Luxembourg:

Continue reading Oncogene to retract breast cancer paper following years-old misconduct investigation

Lancet Oncology updates conflicts of interest statement for cancer-cell phone paper

lanoncThe Lancet Oncology is correcting a 2011 article about the cancer risks of radiofrequency electromagnetic fields, such as those from cell phones, to clarify information about potential conflicts of interest for one of the experts who was involved in its preparation.

The assessments appeared as a monograph for the International Agency for Research on Cancer (IARC).

However, after the 2011 paper “Carcinogenicity of radiofrequency electromagnetic fields” appeared, a reader raised allegations of conflicts of interest among its participants, which sparked a reconsideration of their disclosures.

The correction concerns the conflicts of interest for Niels Kuster of the Swiss Federal Institute of Technology in Zurich, also a board member of the non-profit IT’IS foundation.

Kuster told Retraction Watch he disclosed everything upfront:

Continue reading Lancet Oncology updates conflicts of interest statement for cancer-cell phone paper